Amneal Stock Future Price Prediction


USD 2.10  0.05  2.44%   

Amneal Pharmaceuticals stock price prediction is an act of determining the future value of Amneal Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Amneal Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Amneal Pharmaceuticals and does not consider all of the tangible or intangible factors available from Amneal Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Amneal Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Please continue to Amneal Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Amneal Pharmaceuticals based on different types of headlines from major news networks to social media. The Amneal stock price prediction module provides an analysis of price elasticity to changes in media outlook on Amneal Pharmaceuticals over a specific investment horizon.Using Amneal Pharmaceuticals hype-based prediction, you can estimate the value of Amneal Pharmaceuticals from the perspective of Amneal Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Amneal Pharmaceuticals using Amneal Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Amneal using crowd psychology based on the activity and movement of Amneal Pharmaceuticals' stock price.

Amneal Pharmaceuticals Implied Volatility

Amneal Pharmaceuticals' implied volatility exposes the market's sentiment of Amneal Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amneal Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amneal Pharmaceuticals stock will not fluctuate a lot when Amneal Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Amneal Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Amneal Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Amneal because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Amneal Pharmaceuticals after-hype prediction price

  $ 2.07  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Amneal Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Amneal Pharmaceuticals in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
5 Analysts
LowTarget PriceHigh
Band Projection (param)
LowerMiddle BandUpper
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amneal Pharmaceuticals. Your research has to be compared to or analyzed against Amneal Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Amneal Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Amneal Pharmaceuticals.

Amneal Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Amneal Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amneal Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Amneal Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Amneal Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Amneal Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amneal Pharmaceuticals' historical news coverage. Amneal Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.10 and 6.15, respectively. We have considered Amneal Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 2.10
After-hype Price
Amneal Pharmaceuticals is risky asset. Analysis and calculation of next after-hype price of Amneal Pharmaceuticals is based on 3 months time horizon.

Amneal Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Amneal Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amneal Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amneal Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.67  4.08   0.03   0.34  7 Events / Month0 Events / MonthIn about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility 

Amneal Pharmaceuticals Hype Timeline

Amneal Pharmaceuticals is presently traded for 2.10. The entity has historical hype elasticity of -0.03 and average elasticity to hype of competition of 0.34. Amneal is projected to decline in value after the next headline with the price expected to drop to 2.07. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -1.43% whereas the daily expected return is presently at -0.67%. The volatility of related hype on Amneal Pharmaceuticals is about 816.0% with expected price after next announcement by competition of 2.44. About 68.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.11. Some equities with similar Price to Book (P/B) outperform the market in the long run. Amneal Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 7 days.
Please continue to Amneal Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Amneal Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Amneal Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Amneal Pharmaceuticals' future price movements. Getting to know how Amneal Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amneal Pharmaceuticals may potentially react to the hype associated with one of its peers.
At Risk
IBAIndustrias Bachoco SA 0.50 3 per month 1.05  0.11  2.32 (1.88)  11.96 

Amneal Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Amneal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amneal using various technical indicators. When you analyze Amneal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Amneal Pharmaceuticals Predictive Indicators

The successful prediction of Amneal Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amneal Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amneal Pharmaceuticals based on analysis of Amneal Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amneal Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amneal Pharmaceuticals's related companies.

Story Coverage note for Amneal Pharmaceuticals

The number of cover stories for Amneal Pharmaceuticals depends on current market conditions and Amneal Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amneal Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amneal Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Amneal Pharmaceuticals Short Properties

Amneal Pharmaceuticals' future price predictability will typically decrease when Amneal Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Amneal Pharmaceuticals often depends not only on the future outlook of the potential Amneal Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amneal Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out2.41%
Short Percent Of Float3.56%
Float Shares96.69M
Shares Short Prior Month4.16M
Average Daily Volume Last 10 Day1.19M
Average Daily Volume In Three Month1.06M
Date Short Interest15th of July 2022
Please continue to Amneal Pharmaceuticals Basic Forecasting Models to cross-verify your projections. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for analysis

When running Amneal Pharmaceuticals price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Amneal Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amneal Pharmaceuticals. If investors know Amneal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amneal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Amneal Pharmaceuticals is measured differently than its book value, which is the value of Amneal that is recorded on the company's balance sheet. Investors also form their own opinion of Amneal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Amneal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amneal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Amneal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amneal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Amneal Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amneal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.